Shire, a member of the Takeda group of companies, Lexington, MA, USA.
Pharmerit International, Bethesda, MD, USA.
Qual Life Res. 2019 Dec;28(12):3385-3394. doi: 10.1007/s11136-019-02277-8. Epub 2019 Aug 31.
The Yale-Brown Obsessive Compulsive Scale modified for Binge Eating (Y-BOCS-BE) assesses the obsessiveness of binge eating thoughts and compulsiveness of binge eating behaviors. The findings of this study extend previously published Y-BOCS-BE psychometric evaluations in adults with binge eating disorder (BED).
Data from three phase 3 lisdexamfetamine dimesylate studies in adults with BED (two randomized, double-blind, placebo-controlled short-term efficacy studies; one double-blind, placebo-controlled, randomized-withdrawal maintenance-of-efficacy study) were used. Psychometric evaluations included assessment of Y-BOCS-BE dimensionality, internal consistency, convergent validity, test?retest reliability, and determinations of clinically meaningful improvement using distribution- and anchor-based methods.
Domain specification analyses determined that the Y-BOCS-BE possessed a bifactor structure composed of a general binge eating severity domain and three subdomains (obsessive/compulsive, restraint, and control). Y-BOCS-BE internal consistency was maximized at week 12 (Cronbach?s ?, 0.95) and test?retest reliability was maximized in the 8-week retest interval from week 4 to week 12 across all no-change anchors (r?=?0.74?0.90). Likewise, convergent validity of the Y-BOCS-BE across all validators was maximized at week 12 (all r???0.66). Meaningful improvement for Y-BOCS-BE total scores was estimated to require score reductions of 12 to 17 points depending on the anchor.
The Y-BOCS-BE is a valuable tool for assessing BED symptoms. Maximization of Y-BOCS-BE reliability and validity at later study time points may be related to both treatment effects and improved insight into BED by participants during the study.
耶鲁-布朗强迫量表修订版暴食分量表(Y-BOCS-BE)评估暴食思维的强迫性和暴食行为的强迫性。本研究的结果扩展了先前发表的暴食障碍(BED)成人 Y-BOCS-BE 心理测量评估。
使用了三项成人 BED 的 lisdexamfetamine dimesylate 研究(两项随机、双盲、安慰剂对照的短期疗效研究;一项双盲、安慰剂对照、随机撤药维持疗效研究)的数据。心理测量评估包括 Y-BOCS-BE 维度、内部一致性、收敛效度、测试-重测信度以及使用分布和锚定方法确定临床有意义的改善。
领域指定分析确定 Y-BOCS-BE 具有双因素结构,由一个一般暴食严重程度域和三个子域(强迫/强迫、克制和控制)组成。Y-BOCS-BE 的内部一致性在第 12 周达到最大值(Cronbach's α,0.95),并且在第 4 周到第 12 周的 8 周重测间隔内,所有不变锚的重测信度达到最大值(r=0.74-0.90)。同样,Y-BOCS-BE 在所有有效验证者中的收敛效度在第 12 周达到最大值(所有 r≥0.66)。根据锚的不同,Y-BOCS-BE 总分的有意义改善估计需要减少 12 到 17 分。
Y-BOCS-BE 是评估 BED 症状的有效工具。在研究后期时间点,Y-BOCS-BE 的可靠性和有效性最大化可能与治疗效果以及参与者在研究期间对 BED 的洞察力提高有关。